Did VK2735's VANQUISH-2 Enrollment Milestone Just Reframe Viking Therapeutics' (VKTX) Obesity Drug Ambitions? [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
evaluated over 78 weeks in about 1,000 adults with type 2 diabetes who are obese or overweight, with body-weight change as the primary endpoint. This milestone, combined with prior Phase 2 data showing statistically significant double-digit weight loss and an ongoing oral VK2735 program, further anchors Viking's position in the competitive metabolic disease treatment space. We'll now examine how completing VANQUISH-2 enrollment, building on earlier VK2735 results, may influence Viking Therapeutics' broader investment narrative. Outshine the giants: these 22 early-stage AI stocks could fund your retirement Viking Therapeutics Investment Narrative Recap To own Viking Therapeutics, you need to believe VK2735 can successfully transition from late stage trials into a real obesity treatment franchise despite the company's current losses and lack of revenue. Completion of VANQUISH 2 enrollment helps de risk near term execution on the injectable program, but it does not remove the k
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Where Will Viking Therapeutics Stock Be in 10 Years? [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Where Will Viking Therapeutics Stock Be in 10 Years? [Yahoo! Finance]Yahoo! Finance
- These 5 Biotechs Could Be the Next Big GLP-1 Acquisition Target [Yahoo! Finance]Yahoo! Finance
- 2 Healthcare Stocks Wall Street Analysts Say Could Rally 60% or More [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics, Inc. (VKTX) Declines More Than Market: Some Information for Investors [Yahoo! Finance]Yahoo! Finance
VKTX
Earnings
- 2/11/26 - Miss
VKTX
Sec Filings
- 4/1/26 - Form ARS
- 4/1/26 - Form DEFA14A
- 4/1/26 - Form DEF
- VKTX's page on the SEC website